Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,266,231
-
Share change
-
+489,197
-
Total reported value
-
$2,141,000
-
Price per share
-
$1.70
-
Number of holders
-
18
-
Value change
-
+$810,956
-
Number of buys
-
11
-
Number of sells
-
6
Institutional Holders of TRACON PHARMACEUTICALS INC - COM NEW (TCON) as of Q1 2020
As of 31 Mar 2020,
TRACON PHARMACEUTICALS INC - COM NEW (TCON) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,266,231 shares.
The largest 10 holders included
NEA Management Company, LLC, Linden Advisors LP, RENAISSANCE TECHNOLOGIES LLC, Johnson & Johnson Innovation - JJDC, Inc., 683 Capital Management, LLC, Telemetry Investments, L.L.C., TWO SIGMA INVESTMENTS, LP, JPMORGAN CHASE & CO, MILLENNIUM MANAGEMENT LLC, and Puissance Capital Management LP.
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.